A Study of LY2541546 in Women With Low Bone Mineral Density

NCT01144377 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

154

Enrollment

INDUSTRY

Sponsor class

Conditions

Osteoporosis

Interventions

DRUG: LY2541546
DRUG: Placebo

Sponsor

Eli Lilly and Company